Skip to main content
Log in



We are pleased to announce that Clinical and Experimental Medicine will become a fully open access (OA) on 1 January 2024. As a result, all submissions received from  25thOctober 2023 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access.


Clinical and Experimental Medicine publishes reports of clinical and experimental work concerned with the following fields: clinical chemistry, hematology, immunology, oncology and virology. The major criteria for publication will be clarity, experimental soundness and advances in knowledge. Papers containing new clinical or experimental data, or which are likely to contribute to changes in clinical practice or in thinking about a disease will be given priority due to their immediate importance.
The following types of articles will be considered for publication: invited or unsolicited Reviews and Editorials; Original papers; Short communications; Letters to the Editor. Submission of case reports, clinical trials and epidemiological studies is not encouraged. The Editor-in-Chief will under certain circumstances consider for publication monothematic issues and supplements devoted to congress proceedings. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if the guest editor(s) authors an article in their special issue, they will not handle the peer review process.


This is a transformative journal, you may have access to funding.

  • Francesco Dammacco
Impact factor
4.6 (2022)
5 year impact factor
4.0 (2022)
Submission to first decision (median)
2 days
265,489 (2022)

Latest articles

Journal updates

  • Clinical and Experimental Medicine is transitioning to full open access!

    We are excited to announce that Clinical and Experimental Medicine will become a fully open access (OA) journal in 2024. This means that as of January 2024, we will only be publishing open access articles, meaning content will be freely available to readers worldwide, enabling the widest possible dissemination and reuse. 

    Springer Nature is committed to ensuring our portfolios serve and meet the evolving needs of the research community and that quality research is read and disseminated as widely as possible. Transforming Clinical and Experimental Medicine to full OA reflects our ongoing commitment to driving the transition to open research, and providing researchers with OA publication venues that can amplify their research and enable compliance with funder and institutional OA requirements, while continuing to deliver a high level of author service. See our FAQs for further information.

  • Transition to fully OA FAQ

    Frequently asked questions regarding the transition to fully open access and what this means for the Clinical and Experimental Medicine.

  • Call for Papers: Clinical Practice

    The Clinical Practice topical collection aims to provide clinicians with the latest clinically relevant insights on a range of topics that would result in the enhancement of their knowledge and improvement of patient care. The topics may vary from clinical immunology and rheumatology to hematology, oncology and internal medicine in more general terms. 

    The collection is open to submissions from experienced authors. 

Journal information

Electronic ISSN
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  8. CNKI
  10. Chemical Abstracts Service (CAS)
  11. Dimensions
  12. EBSCO Academic Search
  13. EBSCO Biomedical Reference Collection
  14. EBSCO Discovery Service
  15. EBSCO MasterFILE
  16. EBSCO STM Source
  17. EMBASE
  18. EMBiology
  19. Google Scholar
  20. Japanese Science and Technology Agency (JST)
  21. Journal Citation Reports/Science Edition
  22. Medline
  23. Naver
  24. Norwegian Register for Scientific Journals and Series
  25. OCLC WorldCat Discovery Service
  26. Pathway Studio
  27. Portico
  28. ProQuest-ExLibris Primo
  29. ProQuest-ExLibris Summon
  30. Reaxys
  31. SCImago
  32. SCOPUS
  33. Science Citation Index Expanded (SCIE)
  34. Semantic Scholar
  35. TD Net Discovery Service
  36. UGC-CARE List (India)
  37. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG